Advertisement

Neurourology pp 127-130 | Cite as

Epidemiology of Neurogenic Lower Urinary Tract Dysfunction

  • Marcio A. Averbeck
  • Ulrich Mehnert
  • Riyad Al Mousa
  • Thomas M. Kessler
Chapter

Abstract

Neuro-urological symptoms/dysfunction result from a wide range of neurological disorders [1, 2]. The site of the lesion in the neurological axis determines the general pattern of lower urinary tract dysfunction, which is reflected in the patient’s symptoms (Fig. 10.1) [1]. Data on the prevalence/incidence of the underlying neurological disorder and the consecutive neuro-urological symptoms/dysfunction vary widely reflecting the high variability in the neurological cohort (i.e. early, medium and late stage of disease, limited number of included patients, often low level of evidence studies). The epidemiology of the neuro-urological data is summarized in Table 10.1.

References

  1. 1.
    Panicker JN, Fowler CJ, Kessler TM. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol. 2015;14:720–32.CrossRefGoogle Scholar
  2. 2.
    Groen J, Pannek J, Castro Diaz D, Del Popolo G, Gross T, Hamid R, et al. Summary of European Association of Urology (EAU) guidelines on neuro-urology. Eur Urol. 2016;69:324–33.CrossRefGoogle Scholar
  3. 3.
    Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013. Neuro-Oncology. 2016;18:v1–v75.CrossRefGoogle Scholar
  4. 4.
    Maurice-Williams RS. Micturition symptoms in frontal tumours. J Neurol Neurosurg Psychiatry. 1974;37:431–6.CrossRefGoogle Scholar
  5. 5.
    Averbeck MA, Altaweel W, Manu-Marin A, Madersbacher H. Management of LUTS in patients with dementia and associated disorders. Neurourol Urodyn. 2017;36:245–52.CrossRefGoogle Scholar
  6. 6.
    Fiest KM, Jette N, Roberts JI, Maxwell CJ, Smith EE, Black SE, et al. The prevalence and incidence of dementia: a systematic review and meta-analysis. Can J Neurol Sci. 2016;43(Suppl 1):S3–S50.CrossRefGoogle Scholar
  7. 7.
    Na HR, Park MH, Cho ST, Lee BC, Park S, Kim KH, et al. Urinary incontinence in Alzheimer’s disease is associated with Clinical Dementia Rating-Sum of Boxes and Barthel Activities of Daily Living. Asia Pac Psychiatry. 2015;7:113–20.CrossRefGoogle Scholar
  8. 8.
    Grant RL, Drennan VM, Rait G, Petersen I, Iliffe S. First diagnosis and management of incontinence in older people with and without dementia in primary care: a cohort study using The Health Improvement Network primary care database. PLoS Med. 2013;10:e1001505.CrossRefGoogle Scholar
  9. 9.
    Christensen D, Van Naarden BK, Doernberg NS, Maenner MJ, Arneson CL, Durkin MS, et al. Prevalence of cerebral palsy, co-occurring autism spectrum disorders, and motor functioning—Autism and Developmental Disabilities Monitoring Network, USA, 2008. Dev Med Child Neurol. 2014;56:59–65.CrossRefGoogle Scholar
  10. 10.
    Samijn B, Van Laecke E, Renson C, Hoebeke P, Plasschaert F, Vande Walle J, et al. Lower urinary tract symptoms and urodynamic findings in children and adults with cerebral palsy: a systematic review. Neurourol Urodyn. 2017;36:541–9.CrossRefGoogle Scholar
  11. 11.
    Kuriyama N, Miyajima M, Nakajima M, Kurosawa M, Fukushima W, Watanabe Y, et al. Nationwide hospital-based survey of idiopathic normal pressure hydrocephalus in Japan: Epidemiological and clinical characteristics. Brain Behav. 2017;7:e00635.CrossRefGoogle Scholar
  12. 12.
    Krzastek SC, Bruch WM, Robinson SP, Young HF, Klausner AP. Characterization of lower urinary tract symptoms in patients with idiopathic normal pressure hydrocephalus. Neurourol Urodyn. 2017;36:1167–73.CrossRefGoogle Scholar
  13. 13.
    Krzastek SC, Robinson SP, Young HF, Klausner AP. Improvement in lower urinary tract symptoms across multiple domains following ventriculoperitoneal shunting for idiopathic normal pressure hydrocephalus. Neurourol Urodyn. 2017;36(8):2056–63.CrossRefGoogle Scholar
  14. 14.
    Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol. 2016;15:1257–72.CrossRefGoogle Scholar
  15. 15.
    Ogawa T, Sakakibara R, Kuno S, Ishizuka O, Kitta T, Yoshimura N. Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy. Nat Rev Urol. 2017;14:79–89.CrossRefGoogle Scholar
  16. 16.
    Papatsoris AG, Papapetropoulos S, Singer C, Deliveliotis C. Urinary and erectile dysfunction in multiple system atrophy (MSA). Neurourol Urodyn. 2008;27:22–7.CrossRefGoogle Scholar
  17. 17.
    Kim M, Jung JH, Park J, Son H, Jeong SJ, Oh SJ, et al. Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson’s disease. Parkinsonism Relat Disord. 2015;21:205–10.CrossRefGoogle Scholar
  18. 18.
    Sakakibara R, Panicker J, Finazzi-Agro E, Iacovelli V, Bruschini H, Parkinson’s Disease Subcomittee TNPCiTICS. A guideline for the management of bladder dysfunction in Parkinson’s disease and other gait disorders. Neurourol Urodyn. 2016;35:551–63.CrossRefGoogle Scholar
  19. 19.
    Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJ, et al. The prevalence of Huntington’s disease. Neuroepidemiology. 2016;46:144–53.CrossRefGoogle Scholar
  20. 20.
    Kolenc M, Moharic M, Kobal J, Podnar S. Bladder dysfunction in presymptomatic gene carriers and patients with Huntington’s disease. J Neurol. 2014;261:2360–9.CrossRefGoogle Scholar
  21. 21.
    Townsend N, Nichols M, Scarborough P, Rayner M. Cardiovascular disease in Europe—epidemiological update 2015. Eur Heart J. 2015;36:2696–705.CrossRefGoogle Scholar
  22. 22.
    Tibaek S, Gard G, Klarskov P, Iversen HK, Dehlendorff C, Jensen R. Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey. Neurourol Urodyn. 2008;27:763–71.CrossRefGoogle Scholar
  23. 23.
    Marinkovic SP, Badlani G. Voiding and sexual dysfunction after cerebrovascular accidents. J Urol. 2001;165:359–70.CrossRefGoogle Scholar
  24. 24.
    Rotar M, Blagus R, Jeromel M, Skrbec M, Trsinar B, Vodusek DB. Stroke patients who regain urinary continence in the first week after acute first-ever stroke have better prognosis than patients with persistent lower urinary tract dysfunction. Neurourol Urodyn. 2011;30:1315–8.PubMedGoogle Scholar
  25. 25.
    Tagliaferri F, Compagnone C, Korsic M, Servadei F, Kraus J. A systematic review of brain injury epidemiology in Europe. Acta Neurochir. 2006;148:255–68; discussion 268.CrossRefGoogle Scholar
  26. 26.
    Kulakli F, Koklu K, Ersoz M, Ozel S. Relationship between urinary dysfunction and clinical factors in patients with traumatic brain injury. Brain Inj. 2014;28:323–7.CrossRefGoogle Scholar
  27. 27.
    Singh A, Tetreault L, Kalsi-Ryan S, Nouri A, Fehlings MG. Global prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol. 2014;6:309–31.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Weld KJ, Dmochowski RR. Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Urology. 2000;55:490–4.CrossRefGoogle Scholar
  29. 29.
    Kondo A, Kamihira O, Ozawa H. Neural tube defects: prevalence, etiology and prevention. Int J Urol. 2009;16:49–57.CrossRefGoogle Scholar
  30. 30.
    Sawin KJ, Liu T, Ward E, Thibadeau J, Schechter MS, Soe MM, et al. The National Spina Bifida Patient Registry: profile of a large cohort of participants from the first 10 clinics. J Pediatr. 2015;166:444–50.CrossRefGoogle Scholar
  31. 31.
    Mackenzie IS, Morant SV, Bloomfield GA, MacDonald TM, O’Riordan J. Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database. J Neurol Neurosurg Psychiatry. 2014;85:76–84.CrossRefGoogle Scholar
  32. 32.
    de Seze M, Ruffion A, Denys P, Joseph PA, Perrouin-Verbe B. Genulf. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler. 2007;13:915–28.CrossRefGoogle Scholar
  33. 33.
    Jordan J, Konstantinou K, O’Dowd J. Herniated lumbar disc. BMJ Clin Evid. 2009;2009Google Scholar
  34. 34.
    Yabuki S, Fukumori N, Takegami M, Onishi Y, Otani K, Sekiguchi M, et al. Prevalence of lumbar spinal stenosis, using the diagnostic support tool, and correlated factors in Japan: a population-based study. J Orthop Sci. 2013;18:893–900.CrossRefGoogle Scholar
  35. 35.
    Siracusa G, Sparacino A, Lentini VL. Neurogenic bladder and disc disease: a brief review. Curr Med Res Opin. 2013;29:1025–31.CrossRefGoogle Scholar
  36. 36.
    Lange MM, van de Velde CJ. Urinary and sexual dysfunction after rectal cancer treatment. Nat Rev Urol. 2011;8:51–7.CrossRefGoogle Scholar
  37. 37.
    WHO. Global report on diabetes. http://www.who.int/diabetes/publications/grd-2016/en/. 2016.
  38. 38.
    Amatya B, Khan F, Whishaw M, Pallant JF. Guillain-Barre syndrome: prevalence and long-term factors impacting bladder function in an Australian community cohort. J Clin Neurol. 2013;9:144–50.CrossRefGoogle Scholar
  39. 39.
    Yuan Z, Tang Z, He C, Tang W. Diabetic cystopathy: a review. J Diabetes. 2015;7:442–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  • Marcio A. Averbeck
    • 1
  • Ulrich Mehnert
    • 2
  • Riyad Al Mousa
    • 3
  • Thomas M. Kessler
    • 4
  1. 1.Video-Urodynamics Unit, Department of UrologyMoinhos de Vento HospitalPorto AlegreBrazil
  2. 2.Spinal Cord Injury Center and ResearchUniversity of Zürich, Balgrist University HospitalZürichSwitzerland
  3. 3.King Fahad Specialist HospitalDammamSaudi Arabia
  4. 4.Spinal Cord Injury CenterUniversity of Zürich, Balgrist University HospitalZürichSwitzerland

Personalised recommendations